Clinical Trial Update: Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Bryostatin-1 plus cisplatin for recurrent or advanced cervical cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED